[1]
2025. Silencing CACYBP suppresses lung adenocarcinoma growth via CDK1 inhibition. Biomolecules and Biomedicine. 25, 8 (Mar. 2025), 1801–1815. DOI:https://doi.org/10.17305/bb.2025.11849.